Callaly Lily Clinical Care Team

Team

Using business as a force for good

Calla Lily Clinical Care is a Certified B-Corporation, formed in 2021 out of Callaly, one of Fast Company’s Most Innovative Companies of 2021. B-Corps are a growing global group of organisations committed to using business as a force for good. The company is committed towards meeting the highest standards of social and environmental performance, accountability and transparency. We’re excited about the prospects of our more cost-effective, comfortable and accessible women’s drug-delivery device manufactured with a more sustainable footprint.

 
 
Thang Vo-Ta portrait

Thang Vo-Ta

CEO & Co-founder

Dr Lara Zibners Lohr portrait

Dr Lara Zibners Lohr

Co-founder

Dr Andy Lewis portrait

Prof Andrew Lewis

Principal Scientist

Dr Yasmin Farhatnia portrait

Dr Yasmin Farhatnia

R&D Manager

Dr Stuart Lavery portrait

Dr Stuart Lavery

Board Advisor / Clinical Expert – Fertility

Ewa Radziwon portrait

Ewa Radziwon

Product Development Manager

Dr Kelle Moley portrait

Dr Kelle Moley

Board Advisor

Stuart Princeportrait

Stuart Prince

Chief Financial Officer

Dr Siobhan Quenby portrait

Prof Siobhan Quenby

Board Advisor / Clinical Expert – Miscarriage

Dr Alex Hooi portrait

Dr Alex Hooi

Board Advisor / Inventor

Akeel Khan portrait

Akeel Khan

Chief Product Officer

Dr Serena de Gelidi portrait

Dr Serena de Gelidi

Senior Biomechanical Engineer

Freya Brown portrait

Freya Brown

Microbiome Research Lead

Kaylie Mings portrait

Kaylie Mings

Product Development

Megan Quinlan portrait

Megan Quinlan

Legal & Strategy

Shaun Knights portrait

Shaun Knights

Head of Regulatory & Quality

We use cookies to enhance your website experience. We use necessary cookies to ensure our website functions properly and to keep it secure. These always need to be on. By clicking “Accept cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. Please view our privacy policy for further details.